Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Europe paid the most for piperazine in Q2 2026: USD 3.72/KG, up 3.9% from USD 3.58 in Q1.
Piperazine is a cyclic diamine produced from either ethylene dichloride or monoethanolamine reacted with ammonia, yielding anhydrous or hexahydrate forms depending on the downstream application. Pharmaceutical and USP-grade material commands the largest premium given its stringent purity requirements.
Its best-known pharmaceutical use is as an anthelmintic treating parasitic worm infections, though it also serves as a key intermediate in producing certain antihistamines and, increasingly, in specialty polymer and corrosion inhibitor chemistry.
China hosts the largest share of global production capacity, giving it a persistent cost advantage, while Europe's tighter capacity and stricter pharmaceutical-grade manufacturing standards keep it the priciest of the major producing regions.
Anhydrous piperazine, favoured for its higher purity and easier handling, commands a premium over the hexahydrate form, which retains water of crystallization and is generally the more cost-effective choice for applications where that extra purity isn't required.
Piperazine's role as an anthelmintic has declined somewhat in human medicine as newer antiparasitic drugs have gained favour, shifting a larger relative share of demand toward its pharmaceutical-intermediate and specialty-chemical applications over the past decade.
India's growing generic pharmaceutical manufacturing base has become an increasingly important consumer of piperazine as an intermediate, adding a demand pool that runs somewhat independently of the veterinary and agricultural anthelmintic market that historically dominated global consumption.
China remained the most affordable origin tracked in this report, trading roughly 52% below Europe through Q2 2026. Procurement teams sourcing across borders should factor that spread against their own freight and duty costs before comparing landed price.
Expect steady gains across all four markets through H2 2026 as pharmaceutical intermediate demand continues its gradual growth. China should retain its cost advantage given its scale of production capacity. Europe's premium should persist given its concentrated pharmaceutical-grade manufacturing base and stricter quality standards. Growing demand from specialty polymer and corrosion-inhibitor applications is worth watching as a structural, if still modest, offset to any softening in the traditional anthelmintic market.
Taken together, the 4 markets in this report averaged a 4.6% increase quarter on quarter through the first half of 2026, a pace we expect to broadly continue barring a shift in the underlying cost or demand picture described above.
| Region | 2026 Price Range (USD/KG) | Outlook |
| Global Average | 2.99 - 3.30 | Balance of regional supply and demand conditions |
| China | 2.38 - 2.62 | Ample production capacity met firming feedstock costs |
| United States | 3.32 - 3.66 | Firm pharmaceutical intermediate demand kept US pricing climbing in step with the broader feedstock trend |
| India | 2.67 - 2.94 | Growing domestic pharmaceutical manufacturing demand supported a firm quarter |
| Europe | 3.61 - 3.98 | Strict pharmaceutical-grade manufacturing standards kept Europe at the top of this group |
China reached USD 2.45/KG in Q2 2026, ample production capacity met firming feedstock costs, ranking it the most affordable among the 4 markets this report follows.
Why did the price of Piperazine change in Q2 2026 in China?
Ample production capacity met firming feedstock costs, supporting a steady increase, working out to China trading about 20.6% below this quarter's 4-region average.
Measured against China's own average pace of 2.7% a quarter across the six quarters this report tracks, this move came in faster than that pace.
United States rose 4.3% to USD 3.42/KG in Q2 2026, firm pharmaceutical intermediate demand kept US pricing climbing in step with the broader feedstock trend, placing it the 2nd most expensive across the 4 regions covered in this report.
Why did the price of Piperazine change in Q2 2026 in United States?
Firm pharmaceutical intermediate demand kept US pricing climbing in step with the broader feedstock trend, leaving United States running roughly 10.9% above the 4-region average for the quarter.
That is faster than the 2.3% average quarterly move United States has posted across the six quarters this report tracks.
USD 2.75/KG. That is where India landed in Q2 2026, up 5.0% from USD 2.62/KG in Q1 2026, putting it the 3rd most expensive of the 4 markets tracked this quarter.
Why did the price of Piperazine change in Q2 2026 in India?
Growing domestic pharmaceutical manufacturing demand supported a firm quarter, with India now sitting about 10.9% below the 4-region average this quarter.
India has averaged 2.3% a quarter over the six quarters this report tracks; this move came in faster than that longer-run pace.
Europe's price gained 3.9% to USD 3.72/KG, strict pharmaceutical-grade manufacturing standards kept Europe at the top of this group, making it the priciest of the 4 markets tracked here this quarter.
Why did the price of Piperazine change in Q2 2026 in Europe?
Strict pharmaceutical-grade manufacturing standards kept Europe at the top of this group, which puts Europe roughly 20.6% above the average across the 4 regions this report tracks.
Set against a 2.1% average quarterly pace over the six quarters this report tracks, Europe's move this quarter landed faster than that trend.
China reached USD 2.32/KG in Q1 2026, feedstock costs firmed modestly as the year opened, ranking it the most affordable among the 4 markets this report follows.
Why did the price of Piperazine change in Q1 2026 in China?
Feedstock costs firmed modestly as the year opened, carrying through to a steady early-year increase, working out to China trading about 21.4% below this quarter's 4-region average.
Measured against China's own average pace of 2.7% a quarter across the six quarters this report tracks, this move came in slower than that pace.
United States rose 1.8% to USD 3.28/KG in Q1 2026, early-year pharmaceutical sector restocking supported a firm start to 2026, placing it the 2nd most expensive across the 4 regions covered in this report.
Why did the price of Piperazine change in Q1 2026 in United States?
Early-year pharmaceutical sector restocking supported a firm start to 2026, leaving United States running roughly 11.2% above the 4-region average for the quarter.
That is slower than the 2.3% average quarterly move United States has posted across the six quarters this report tracks.
USD 2.62/KG. That is where India landed in Q1 2026, up 1.7% from USD 2.58/KG in Q4 2025, putting it the 3rd most expensive of the 4 markets tracked this quarter.
Why did the price of Piperazine change in Q1 2026 in India?
Growing domestic demand carried prices higher as the new year began, with India now sitting about 11.2% below the 4-region average this quarter.
India has averaged 2.3% a quarter over the six quarters this report tracks; this move came in slower than that longer-run pace.
Europe's price gained 1.7% to USD 3.58/KG, consistent demand from the region's established pharmaceutical industry supported a steady early-year gain, making it the priciest of the 4 markets tracked here this quarter.
Why did the price of Piperazine change in Q1 2026 in Europe?
Consistent demand from the region's established pharmaceutical industry supported a steady early-year gain, which puts Europe roughly 21.4% above the average across the 4 regions this report tracks.
Set against a 2.1% average quarterly pace over the six quarters this report tracks, Europe's move this quarter landed slower than that trend.
The global average climbed steadily across the window, from USD 2.75/KG in Q1 2025 to USD 3.08 by Q2 2026, a gain of 12.2% over six quarters.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 3.08 | +4.6% | ↑ Rising |
| Q1 2026 | 2.95 | +1.8% | ↑ Rising |
| Q4 2025 | 2.90 | +1.8% | ↑ Rising |
| Q3 2025 | 2.85 | +1.8% | ↑ Rising |
| Q2 2025 | 2.80 | +1.8% | ↑ Rising |
| Q1 2025 | 2.75 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
Looking back at 2025, the global piperazine average ran from about USD 2.75/KG in Q1 to USD 2.90 by Q4, a 5.4% increase across the year.
China prices moved from about USD 2.15/KG in Q1 2025 to USD 2.28 by Q4, up roughly 5.9%. China closed the year ranked 4 of the 4 markets this report tracks.
United States prices moved from about USD 3.05/KG in Q1 2025 to USD 3.22 by Q4, up roughly 5.6%, leaving United States in 2 place among the 4 tracked markets heading into the new year.
India prices moved from about USD 2.45/KG in Q1 2025 to USD 2.58 by Q4, up roughly 5.2%. That left India ranked 3 of 4 tracked markets heading into 2026.
Europe prices moved from about USD 3.35/KG in Q1 2025 to USD 3.52 by Q4, up roughly 5.1%, placing Europe 1 of 4 tracked markets as 2025 closed out.
Expert Market Research: Your Source for Real-Time Piperazine Price Intelligence
Tracking piperazine prices means tracking what actually moves them: ethylene dichloride, monoethanolamine, and ammonia costs, regional demand shifts, and the policy decisions that touch both. Our team maintains that view across every region in this report, refreshing it as conditions change.
Rather than a single static figure, our forecasts blend capacity data, feedstock cost trends, and demand signals from across the regions we cover, built specifically to support procurement budgeting and supplier negotiations.
Reach out to our analysts for a deeper regional breakdown, historical data extending beyond the six quarters shown here, or a custom piperazine sourcing analysis tailored to your specific procurement footprint.
We track anhydrous and hexahydrate piperazine pricing separately, since the choice between the two forms depends on a buyer's specific application rather than price alone, and we watch pharmaceutical-intermediate demand as a distinct thread from the traditional anthelmintic market.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Piperazine is a cyclic diamine produced from either ethylene dichloride or monoethanolamine reacted with ammonia, yielding anhydrous or hexahydrate forms depending on the downstream application. Pharmaceutical and USP-grade material commands the largest premium given its stringent purity requirements.
In Q2 2026, it averaged USD 2.45/KG in China, USD 3.42/KG in United States, USD 2.75/KG in India, USD 3.72/KG in Europe, with Europe the priciest of the 4 markets tracked in this report.
The global average moved from USD 2.90/KG in Q4 2025 to USD 2.95 in Q1 2026, then to USD 3.08 by Q2, a 6.4% increase across the two quarters.
Ample production capacity met firming feedstock costs, and the other regions covered here moved for largely the same underlying reasons, filtered through their own local supply and demand conditions.
Expect steady gains across all four markets through H2 2026 as pharmaceutical intermediate demand continues its gradual growth.
Europe sits at the top given its cost and demand structure, while China trades lowest of the 4 markets tracked here. The gap between them reflects local production costs, import exposure, and demand intensity, and it is worth revisiting each quarter since the ranking can shift as input costs move.
Ethylene dichloride and monoethanolamine feedstock costs; Pharmaceutical and veterinary anthelmintic demand, the highest-value end use; Specialty polymer and corrosion inhibitor demand, a smaller but growing secondary market, along with broader macroeconomic conditions across the 4 regions this report tracks.
India's growing generic pharmaceutical manufacturing base has become an increasingly important consumer of piperazine as an intermediate, adding a demand pool that runs somewhat independently of the veterinary and agricultural anthelmintic market that historically dominated global consumption.
Beyond treating parasitic worm infections in humans and animals, piperazine serves as a chemical intermediate in producing certain antihistamine medications, and increasingly in specialty polymer chemistry and corrosion inhibitor formulations, a smaller but growing share of overall demand.
Monthly, though our analysts flag any material shift in feedstock costs or regional demand as soon as it emerges.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.